Cafepharma Today

May 20 2025 - FDA outlines stricter Covid vaccine booster approval standards for healthy people
FDA outlines stricter Covid vaccine booster approval standards for healthy people
AHA warns tariffs could worsen drug shortages, pushes for long-term reform
Surveyed via text, HCPs say they want more interactions with pharma
Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

How Do These Pharmas Really Boost Their Returns?
Motley Fool
Thursday, April 21, 2011 - 10:56am
tags:
Merck, Pfizer, Abbott Laboratories, GSK, ROE
Should You Sell Abbott Labs Today?
Motley Fool
Thursday, April 21, 2011 - 10:37am
tags:
Abbott Laboratories
Titan Should Be on the Biotech Watch Lists Right Now
Seeking Alpha
Thursday, April 21, 2011 - 9:54am
tags:
Titan, Novartis, Fanapt
Biogen revenue, profit up in Q1
Bizjournals.com
Thursday, April 21, 2011 - 9:50am
tags:
Biogen Idec, earnings
Depomed: Light-Risk Small Pharma With Huge Potential
Seeking Alpha
Thursday, April 21, 2011 - 9:49am
tags:
Depomed
New generics quickly grab 80% of sales volume
Fierce Pharma
Thursday, April 21, 2011 - 9:25am
tags:
prescription data, generics
Roche's Genentech Sues Novartis Unit Claiming Infringement of Valcyte Drug
Bloomberg
Thursday, April 21, 2011 - 9:23am
tags:
Genentech, Novartis, Valcyte, generics, patents, AIDS
Merck, Vertex Prep for Hep C Drug Panels
TheStreet.com
Thursday, April 21, 2011 - 9:21am
tags:
Merck, Vertex Pharmaceuticals, hepatitis C, FDA, Boceprevir, Telaprevir, advisory panels
Pfizer, Shanghai Pharma Agree to Explore China Cooperation
Bloomberg
Thursday, April 21, 2011 - 9:19am
tags:
Pfizer, China, Shanghai Pharmaceutical
Gilead Q1 profit dips to $651.1M
Bizjournals.com
Wednesday, April 20, 2011 - 7:07pm
tags:
earnings, Gilead Sciences
Amgen Beats on Top and Bottom Lines, but Shares Drop
Bizjournals.com
Wednesday, April 20, 2011 - 7:00pm
tags:
Amgen, earnings
Dynavax gets $6M for start of human tests of lupus treatment
Bizjournals.com
Wednesday, April 20, 2011 - 6:55pm
tags:
lupus, GSK, Dynavax, DV1179
Turnaround at Johnson & Johnson? Let's Do Some Math.
Motley Fool
Wednesday, April 20, 2011 - 6:54pm
tags:
JNJ
CROs scramble as Big Pharma lines up strategic partnerships
Fierce Biotech
Wednesday, April 20, 2011 - 12:20pm
tags:
CROs, Big Pharma, R&D, Covance, PPD, Parexel, Charles River Laboratories, ICON, Kendle, Quintiles
J&J defends executive pay to institutional investors
Fierce Pharma
Wednesday, April 20, 2011 - 12:07pm
tags:
JNJ, executive pay
Gilead Sciences signs licensing deal with MicroDose for potential respiratory virus drug
Yahoo/AP
Wednesday, April 20, 2011 - 12:06pm
tags:
Gilead Sciences, RSV, MicroDose Therapeutx, MDT-637
Elan turns 1Q profit as Tysabri sales rise
Yahoo/AP
Wednesday, April 20, 2011 - 12:04pm
tags:
Elan, earnings
FDA approves Genentech vasculitis treatment
Bizjournals.com
Wednesday, April 20, 2011 - 12:04pm
tags:
FDA, Genentech, vasculitis, Rituxan
Lilly Will Pay Investors For Patience
Investopedia
Wednesday, April 20, 2011 - 12:02pm
tags:
invesors, Eli Lilly
Mylan now selling generic version of Novartis' herpes drug Famvir
Yahoo/AP
Wednesday, April 20, 2011 - 12:01pm
tags:
Mylan, generics, Famvir, Novartis, herpes zoster

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.